{"variation_id":"8152","id":"RCV000008630","variation_archive_id":"VCV000008152","date_last_evaluated":"2015-05-18","version":"4","title":"CX3CR1:c.[841G\u003eA;935C\u003eT] (p.Val294Ile;Thr280Met) AND Coronary artery disease, resistance to","submission_count":"1","trait_set_id":"2228","review_status":"no assertion criteria provided","interpretation":"protective"}
{"variation_id":"8152","id":"RCV000008629","variation_archive_id":"VCV000008152","date_last_evaluated":"2014-09-05","version":"4","title":"CX3CR1:c.[841G\u003eA;935C\u003eT] (p.Val294Ile;Thr280Met) AND Human immunodeficiency virus type 1, rapid progression to AIDS","submission_count":"1","trait_set_id":"2227","review_status":"no assertion criteria provided","interpretation":"Pathogenic"}
{"variation_id":"8152","id":"RCV000023109","variation_archive_id":"VCV000008152","date_last_evaluated":"2013-12-01","version":"4","title":"CX3CR1:c.[841G\u003eA;935C\u003eT] (p.Val294Ile;Thr280Met) AND Age-related macular degeneration 12","submission_count":"1","trait_set_id":"6838","review_status":"no assertion criteria provided","interpretation":"risk factor"}
{"variation_id":"12610","id":"RCV000013444","variation_archive_id":"VCV000012610","date_last_evaluated":"2017-04-03","version":"20","title":"NM_176795.4(HRAS):c.173C\u003eT (p.Thr58Ile) AND Costello syndrome","submission_count":"4","trait_set_id":"3420","review_status":"reviewed by expert panel","interpretation":"Pathogenic"}
{"variation_id":"3520","id":"RCV000211336","variation_archive_id":"VCV000003520","date_last_evaluated":"2016-07-11","version":"1","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND carboplatin response - Efficacy","submission_count":"1","trait_set_id":"26870","review_status":"reviewed by expert panel","interpretation":"drug response"}
{"variation_id":"3520","id":"RCV000761447","variation_archive_id":"VCV000003520","date_last_evaluated":"2017-12-30","version":"1","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND Venous thrombosis","submission_count":"1","trait_set_id":"6404","review_status":"no assertion criteria provided","interpretation":"Uncertain significance"}
{"variation_id":"3520","id":"RCV000211133","variation_archive_id":"VCV000003520","date_last_evaluated":"2016-07-11","version":"1","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND cyclophosphamide response - Toxicity/ADR","submission_count":"1","trait_set_id":"26869","review_status":"reviewed by expert panel","interpretation":"drug response"}
{"variation_id":"3520","id":"RCV000427078","variation_archive_id":"VCV000003520","date_last_evaluated":"2016-03-10","version":"1","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND Neoplasm of stomach","submission_count":"1","trait_set_id":"6728","review_status":"no assertion provided","interpretation":"not provided"}
{"variation_id":"3520","id":"RCV000428048","variation_archive_id":"VCV000003520","date_last_evaluated":"2016-04-25","version":"1","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND not specified","submission_count":"1","trait_set_id":"9590","review_status":"criteria provided, single submitter","interpretation":"Benign"}
{"variation_id":"3520","id":"RCV000417131","variation_archive_id":"VCV000003520","date_last_evaluated":"2018-05-14","version":"1","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND methotrexate response - Dosage, Efficacy, Toxicity/ADR","submission_count":"1","trait_set_id":"35046","review_status":"reviewed by expert panel","interpretation":"drug response"}
{"variation_id":"3520","id":"RCV000144921","variation_archive_id":"VCV000003520","version":"1","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND Gastrointestinal stroma tumor","submission_count":"1","trait_set_id":"6607","review_status":"no assertion criteria provided","interpretation":"Uncertain significance"}
{"variation_id":"3520","id":"RCV000259890","variation_archive_id":"VCV000003520","date_last_evaluated":"2016-06-14","version":"1","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND Neural tube defects, folate-sensitive","submission_count":"1","trait_set_id":"6564","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
{"variation_id":"3520","id":"RCV000003697","variation_archive_id":"VCV000003520","date_last_evaluated":"2019-06-11","version":"7","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND MTHFR deficiency, thermolabile type","submission_count":"2","trait_set_id":"916","review_status":"no assertion criteria provided","interpretation":"Conflicting interpretations of pathogenicity"}
{"variation_id":"3520","id":"RCV000153516","variation_archive_id":"VCV000003520","date_last_evaluated":"2017-05-02","version":"4","title":"NM_005957.4(MTHFR):c.665C\u003eT (p.Ala222Val) AND not provided","submission_count":"2","trait_set_id":"9460","review_status":"criteria provided, multiple submitters, no conflicts","interpretation":"Uncertain significance, other"}
{"variation_id":"37594","id":"RCV000031175","variation_archive_id":"VCV000037594","date_last_evaluated":"2008-09-04","version":"3","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND Breast-ovarian cancer, familial 1","submission_count":"1","trait_set_id":"1917","review_status":"no assertion criteria provided","interpretation":"Uncertain significance"}
{"variation_id":"37594","id":"RCV000479398","variation_archive_id":"VCV000037594","date_last_evaluated":"2018-09-25","version":"3","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND not provided","submission_count":"1","trait_set_id":"9460","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"37594","id":"RCV000240737","variation_archive_id":"VCV000037594","date_last_evaluated":"2015-11-01","version":"1","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND Neoplasm of the breast","submission_count":"1","trait_set_id":"12285","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"37594","id":"RCV000458634","variation_archive_id":"VCV000037594","date_last_evaluated":"2018-05-21","version":"3","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND Hereditary breast and ovarian cancer syndrome","submission_count":"1","trait_set_id":"7920","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"37594","id":"RCV000764128","variation_archive_id":"VCV000037594","date_last_evaluated":"2018-10-31","version":"1","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND multiple conditions","submission_count":"1","trait_set_id":"46395","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"37594","id":"RCV000219296","variation_archive_id":"VCV000037594","date_last_evaluated":"2016-04-19","version":"2","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND Hereditary cancer-predisposing syndrome","submission_count":"2","trait_set_id":"13598","review_status":"criteria provided, conflicting interpretations","interpretation":"Conflicting interpretations of pathogenicity"}
{"variation_id":"46503","id":"RCV000727222","variation_archive_id":"VCV000046503","date_last_evaluated":"2018-05-30","version":"1","title":"NM_033056.3(PCDH15):c.5565C\u003eT (p.Ala1855=) AND not provided","submission_count":"1","trait_set_id":"9460","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"46503","id":"RCV000326661","variation_archive_id":"VCV000046503","date_last_evaluated":"2016-06-14","version":"1","title":"NM_033056.3(PCDH15):c.5565C\u003eT (p.Ala1855=) AND Nonsyndromic Hearing Loss, Recessive","submission_count":"1","trait_set_id":"33370","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"46503","id":"RCV000381540","variation_archive_id":"VCV000046503","date_last_evaluated":"2016-06-14","version":"1","title":"NM_033056.3(PCDH15):c.5565C\u003eT (p.Ala1855=) AND Retinitis pigmentosa-deafness syndrome","submission_count":"1","trait_set_id":"2631","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"46503","id":"RCV000039762","variation_archive_id":"VCV000046503","date_last_evaluated":"2017-11-21","version":"5","title":"NM_033056.3(PCDH15):c.5565C\u003eT (p.Ala1855=) AND not specified","submission_count":"2","trait_set_id":"9590","review_status":"criteria provided, multiple submitters, no conflicts","interpretation":"Likely benign"}
{"variation_id":"48176","id":"RCV000041467","variation_archive_id":"VCV000048176","date_last_evaluated":"2017-04-25","version":"5","title":"NM_194248.2(OTOF):c.1630C\u003eT (p.Arg544Cys) AND not specified","submission_count":"1","trait_set_id":"9590","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"48176","id":"RCV000726979","variation_archive_id":"VCV000048176","date_last_evaluated":"2016-12-20","version":"1","title":"NM_194248.2(OTOF):c.1630C\u003eT (p.Arg544Cys) AND not provided","submission_count":"1","trait_set_id":"9460","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"48176","id":"RCV000357820","variation_archive_id":"VCV000048176","date_last_evaluated":"2016-06-14","version":"1","title":"NM_194248.2(OTOF):c.1630C\u003eT (p.Arg544Cys) AND Nonsyndromic Hearing Loss, Recessive","submission_count":"1","trait_set_id":"33370","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"7884","id":"RCV000778139","variation_archive_id":"VCV000007884","date_last_evaluated":"2019-04-05","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND ABCA4-Related Disorders","submission_count":"1","trait_set_id":"33431","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"7884","id":"RCV000504806","variation_archive_id":"VCV000007884","date_last_evaluated":"2015-01-01","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Cone/cone-rod dystrophy","submission_count":"1","trait_set_id":"33742","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"7884","id":"RCV000259072","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-11-17","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not specified","submission_count":"1","trait_set_id":"9590","review_status":"criteria provided, single submitter","interpretation":"Benign"}
{"variation_id":"7884","id":"RCV000393726","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-06-14","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Macular degeneration","submission_count":"1","trait_set_id":"33398","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
{"variation_id":"7884","id":"RCV000285333","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-06-14","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Cone-Rod Dystrophy, Recessive","submission_count":"1","trait_set_id":"33383","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
{"variation_id":"7884","id":"RCV000393715","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-06-14","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Retinitis Pigmentosa, Recessive","submission_count":"1","trait_set_id":"33382","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
{"variation_id":"7884","id":"RCV000340261","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-06-14","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt Disease, Recessive","submission_count":"1","trait_set_id":"33430","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
{"variation_id":"7884","id":"RCV000008335","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-01-01","version":"6","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt disease 1","submission_count":"2","trait_set_id":"1448","review_status":"criteria provided, single submitter","interpretation":"Likely pathogenic"}
{"variation_id":"7884","id":"RCV000078671","variation_archive_id":"VCV000007884","date_last_evaluated":"2018-11-07","version":"7","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","submission_count":"2","trait_set_id":"9460","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"13972","id":"RCV000015006","variation_archive_id":"VCV000013972","date_last_evaluated":"2003-11-17","version":"9","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Non-Hodgkin lymphoma","submission_count":"1","trait_set_id":"3352","review_status":"no assertion criteria provided","interpretation":"Pathogenic"}
{"variation_id":"13972","id":"RCV000426339","variation_archive_id":"VCV000013972","date_last_evaluated":"2015-07-14","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Cutaneous melanoma","submission_count":"1","trait_set_id":"12074","review_status":"no assertion criteria provided","interpretation":"Pathogenic"}
{"variation_id":"13972","id":"RCV000037932","variation_archive_id":"VCV000013972","date_last_evaluated":"2012-06-11","version":"2","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Non-small cell lung cancer","submission_count":"1","trait_set_id":"4069","review_status":"criteria provided, single submitter","interpretation":"Pathogenic"}
{"variation_id":"13972","id":"RCV000443065","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Neoplasm of brain","submission_count":"1","trait_set_id":"11864","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"13972","id":"RCV000433779","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Adrenocortical carcinoma","submission_count":"1","trait_set_id":"35132","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"13972","id":"RCV000423919","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Malignant melanoma of skin","submission_count":"1","trait_set_id":"6369","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"13972","id":"RCV000426107","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Lung adenocarcinoma","submission_count":"1","trait_set_id":"3349","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"13972","id":"RCV000437006","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Transitional cell carcinoma of the bladder","submission_count":"1","trait_set_id":"35142","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"13972","id":"RCV000418680","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Chronic lymphocytic leukemia","submission_count":"1","trait_set_id":"9305","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"13972","id":"RCV000443882","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Neoplasm of the large intestine","submission_count":"1","trait_set_id":"31428","review_status":"no assertion criteria provided","interpretation":"Pathogenic"}
{"variation_id":"13972","id":"RCV000435875","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Squamous cell carcinoma of the head and neck","submission_count":"1","trait_set_id":"1717","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"13972","id":"RCV000442759","variation_archive_id":"VCV000013972","date_last_evaluated":"2016-05-31","version":"1","title":"NM_004333.4(BRAF):c.1781A\u003eG (p.Asp594Gly) AND Multiple myeloma","submission_count":"1","trait_set_id":"6478","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
{"variation_id":"822","id":"RCV000210085","variation_archive_id":"VCV000000822","date_last_evaluated":"2015-11-20","version":"1","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND Colorectal cancer, susceptibility to","submission_count":"1","trait_set_id":"1570","review_status":"criteria provided, single submitter","interpretation":"risk factor"}
{"variation_id":"822","id":"RCV000680453","variation_archive_id":"VCV000000822","date_last_evaluated":"2018-06-01","version":"1","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND Familial adenomatous polyposis","submission_count":"1","trait_set_id":"35108","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"822","id":"RCV000000865","variation_archive_id":"VCV000000822","date_last_evaluated":"2003-12-01","version":"4","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND Breast cancer, susceptibility to","submission_count":"1","trait_set_id":"216","review_status":"no assertion criteria provided","interpretation":"risk factor"}
{"variation_id":"822","id":"RCV000238802","variation_archive_id":"VCV000000822","date_last_evaluated":"2015-11-24","version":"1","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND Familial multiple polyposis syndrome","submission_count":"1","trait_set_id":"8942","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
{"variation_id":"822","id":"RCV000722046","variation_archive_id":"VCV000000822","date_last_evaluated":"2017-01-01","version":"1","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND Carcinoma of colon","submission_count":"1","trait_set_id":"1735","review_status":"criteria provided, single submitter","interpretation":"risk factor"}
{"variation_id":"822","id":"RCV000000864","variation_archive_id":"VCV000000822","date_last_evaluated":"2019-04-01","version":"3","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND Adenomatous polyposis coli, susceptibility to","submission_count":"1","trait_set_id":"215","review_status":"no assertion criteria provided","interpretation":"risk factor"}
{"variation_id":"822","id":"RCV000120049","variation_archive_id":"VCV000000822","date_last_evaluated":"2017-02-08","version":"3","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND not specified","submission_count":"3","trait_set_id":"9590","review_status":"criteria provided, multiple submitters, no conflicts","interpretation":"Uncertain significance"}
{"variation_id":"822","id":"RCV000115087","variation_archive_id":"VCV000000822","date_last_evaluated":"2018-08-01","version":"12","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND Hereditary cancer-predisposing syndrome","submission_count":"4","trait_set_id":"13598","review_status":"criteria provided, multiple submitters, no conflicts","interpretation":"Pathogenic/Likely pathogenic, risk factor"}
{"variation_id":"822","id":"RCV000020088","variation_archive_id":"VCV000000822","date_last_evaluated":"2018-11-21","version":"10","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND Familial adenomatous polyposis 1","submission_count":"6","trait_set_id":"6265","review_status":"criteria provided, conflicting interpretations","interpretation":"Conflicting interpretations of pathogenicity, risk factor"}
{"variation_id":"822","id":"RCV000034388","variation_archive_id":"VCV000000822","date_last_evaluated":"2018-06-20","version":"5","title":"NM_000038.5(APC):c.3920T\u003eA (p.Ile1307Lys) AND not provided","submission_count":"6","trait_set_id":"9460","review_status":"criteria provided, conflicting interpretations","interpretation":"Conflicting interpretations of pathogenicity, risk factor"}
{"variation_id":"208761","id":"RCV000190782","variation_archive_id":"VCV000208761","date_last_evaluated":"2015-04-08","version":"2","title":"NM_172107.3(KCNQ2):c.693G\u003eC (p.Glu231Asp) AND Inborn genetic diseases","submission_count":"1","trait_set_id":"25797","review_status":"criteria provided, single submitter","interpretation":"Likely pathogenic"}
{"variation_id":"17674","id":"RCV000476410","variation_archive_id":"VCV000017674","date_last_evaluated":"2017-02-23","version":"1","title":"NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs) AND Familial cancer of breast","submission_count":"1","trait_set_id":"774","review_status":"criteria provided, single submitter","interpretation":"Pathogenic"}
{"variation_id":"17674","id":"RCV000735453","variation_archive_id":"VCV000017674","date_last_evaluated":"2010-07-08","version":"1","title":"NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs) AND Breast and/or ovarian cancer","submission_count":"1","trait_set_id":"20192","review_status":"no assertion criteria provided","interpretation":"Pathogenic"}
{"variation_id":"17674","id":"RCV000238776","variation_archive_id":"VCV000017674","date_last_evaluated":"2016-07-01","version":"1","title":"NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs) AND not specified","submission_count":"1","trait_set_id":"9590","review_status":"criteria provided, single submitter","interpretation":"Pathogenic"}
{"variation_id":"17674","id":"RCV000131887","variation_archive_id":"VCV000017674","date_last_evaluated":"2018-03-15","version":"6","title":"NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs) AND Hereditary cancer-predisposing syndrome","submission_count":"2","trait_set_id":"13598","review_status":"criteria provided, multiple submitters, no conflicts","interpretation":"Pathogenic"}
{"variation_id":"17674","id":"RCV000159924","variation_archive_id":"VCV000017674","date_last_evaluated":"2018-12-19","version":"4","title":"NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs) AND not provided","submission_count":"2","trait_set_id":"9460","review_status":"criteria provided, multiple submitters, no conflicts","interpretation":"Pathogenic"}
{"variation_id":"17674","id":"RCV000048431","variation_archive_id":"VCV000017674","date_last_evaluated":"2018-07-02","version":"13","title":"NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs) AND Hereditary breast and ovarian cancer syndrome","submission_count":"6","trait_set_id":"7920","review_status":"criteria provided, multiple submitters, no conflicts","interpretation":"Pathogenic"}
{"variation_id":"17674","id":"RCV000019243","variation_archive_id":"VCV000017674","date_last_evaluated":"2016-04-22","version":"16","title":"NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs) AND Breast-ovarian cancer, familial 1","submission_count":"11","trait_set_id":"1917","review_status":"reviewed by expert panel","interpretation":"Pathogenic"}
{"variation_id":"424841","id":"RCV000416302","variation_archive_id":"VCV000424841","version":"1","title":"NM_000051.3(ATM):c.[1236-2A\u003eT];[497-1G\u003eA] AND Ataxia-telangiectasia syndrome","submission_count":"1","trait_set_id":"770","review_status":"no assertion criteria provided","interpretation":"Uncertain significance"}
{"variation_id":"549768","id":"RCV000664336","variation_archive_id":"VCV000549768","date_last_evaluated":"2018-05-04","version":"1","title":"NM_020975.4:c.[1901G\u003eA];[200G\u003eA;874G\u003eA;2944C\u003eT] AND Multiple endocrine neoplasia, type 2","submission_count":"1","trait_set_id":"8702","review_status":"no assertion criteria provided","interpretation":"Pathogenic"}
